Becton Dickinson and Co. (BDX) PT Raised to $192.00 at Jefferies Group

becton-dickinson-and-co-bdx-pt-raised-to-19200-at-jefferies-group.jpg

Becton Dickinson and Co. (NYSE:BDX) had its price objective boosted by research analysts at Jefferies Group from $190.00 to $192.00 in a report issued on Thursday. The brokerage presently has a “buy” rating on the stock. Jefferies Group’s target price suggests a potential upside of 9.59% from the company’s previous close.
Other analysts have also recently issued research reports about the company. Leerink Swann reiterated a “hold” rating on shares of Becton Dickinson and in a research report on Sunday, May 8th. Morgan Stanley restated a “hold” rating on shares of Becton Dickinson and in a research report on Sunday, May 8th. Argus restated a “buy” rating on shares of Becton Dickinson and in a research report on Sunday, June 12th. Bank of America Corp. restated a “buy” rating on shares of Becton Dickinson and in a research report on Thursday, May 12th. Finally, JPMorgan Chase & Co. restated a “buy” rating on shares of Becton Dickinson and in a research report on Tuesday, May 3rd. Eight equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have issued a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $169.46.
Shares of Becton Dickinson and (NYSE:BDX) traded down 0.47% during trading on Thursday, hitting $175.20. The company’s stock had a trading volume of 998,066 shares. Becton Dickinson and has a one year low of $128.87 and a one year high of $178.79. The stock has a market cap of $37.30 billion, a PE ratio of 33.44 and a beta of 0.97. The company has a 50-day moving average price of $174.95 and a 200-day moving average price of $165.49.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/18/becton-dickinson-and-co-bdx-pt-raised-to-192-00-at-jefferies-group.html

Becton Dickinson and (NYSE:BDX) last posted its earnings results on Thursday, August 4th. The company reported $2.35 EPS for the quarter, topping the Zacks’ consensus estimate of $2.21 by $0.14. Becton Dickinson and had a return on equity of 24.26% and a net margin of 9.24%. The business had revenue of $3.20 billion for the quarter, compared to analysts’ expectations of $3.21 billion. During the same quarter in the previous year, the firm earned $2.05 earnings per share. The business’s revenue was up 2.5% compared to the same quarter last year. Equities analysts predict that Becton Dickinson and will post $8.57 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Friday, September 30th. Stockholders of record on Friday, September 9th will be paid a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a dividend yield of 1.51%. The ex-dividend date is Wednesday, September 7th. Becton Dickinson and’s dividend payout ratio (DPR) is 50.19%.
In related news, insider Gary M. Cohen sold 29,367 shares of Becton Dickinson and stock in a transaction that occurred on Thursday, August 11th. The stock was sold at an average price of $176.81, for a total transaction of $5,192,379.27. Following the completion of the transaction, the insider now directly owns 125,870 shares in the company, valued at approximately $22,255,074.70. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Linda M. Tharby sold 11,704 shares of Becton Dickinson and stock in a transaction that occurred on Tuesday, September 6th. The stock was sold at an average price of $177.27, for a total value of $2,074,768.08. Following the transaction, the insider now owns 22,146 shares of the company’s stock, valued at $3,925,821.42. The disclosure for this sale can be found here. Insiders own 1.60% of the company’s stock.
Hedge funds and other institutional investors have recently modified their holdings of the company. Price T Rowe Associates Inc. MD increased its position in shares of Becton Dickinson and by 0.6% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 16,929,774 shares of the company’s stock valued at $2,608,709,000 after buying an additional 93,498 shares in the last quarter. Vanguard Group Inc. increased its position in shares of Becton Dickinson and by 2.0% in the second quarter. Vanguard Group Inc. now owns 14,472,294 shares of the company’s stock valued at $2,454,357,000 after buying an additional 277,081 shares in the last quarter. Jarislowsky Fraser Ltd increased its position in shares of Becton Dickinson and by 1,050.3% in the second quarter. Jarislowsky Fraser Ltd now owns 10,373,430 shares of the company’s stock valued at $531,241,000 after buying an additional 9,471,594 shares in the last quarter. BlackRock Institutional Trust Company N.A. increased its position in shares of Becton Dickinson and by 3.4% in the second quarter. BlackRock Institutional Trust Company N.A. now owns 5,848,941 shares of the company’s stock valued at $991,922,000 after buying an additional 189,911 shares in the last quarter. Finally, BlackRock Fund Advisors increased its position in shares of Becton Dickinson and by 11.1% in the second quarter. BlackRock Fund Advisors now owns 4,345,829 shares of the company’s stock valued at $737,009,000 after buying an additional 433,904 shares in the last quarter. Hedge funds and other institutional investors own 82.02% of the company’s stock.
About Becton Dickinson and
Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.

Receive News & Ratings for Becton Dickinson and Co. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Becton Dickinson and Co. and related companies with MarketBeat.com’s FREE daily email newsletter.

Be the first to comment on "Becton Dickinson and Co. (BDX) PT Raised to $192.00 at Jefferies Group"

Leave a comment

Your email address will not be published.


*